Trial record 1 of 1 for:    NCT01536054
Previous Study | Return to List | Next Study

Sirolimus and Vaccine Therapy in Treating Patients With Stage II-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01536054
Recruitment Status : Active, not recruiting
First Posted : February 20, 2012
Last Update Posted : March 29, 2018
National Cancer Institute (NCI)
Sanofi Pasteur, a Sanofi Company
Information provided by (Responsible Party):
Roswell Park Cancer Institute

No Study Results Posted on for this Study
  Recruitment Status : Active, not recruiting
  Actual Primary Completion Date : April 21, 2015
  Estimated Study Completion Date : September 1, 2018